In France, the average family impacted by amyotrophic lateral sclerosis (ALS) has to pay thousands in out-of-pocket expenses to…
Articles by Marisa Wexler, MS
The Muscular Dystrophy Association (MDA) will return to New York City on June 4 for its 26th annual Wings…
Nearly half of the people with amyotrophic lateral sclerosis (ALS) treated with masitinib in a clinical trial survived…
Long-term exposure to air pollution is not associated with an altered, or increased, risk of amyotrophic lateral sclerosis (ALS).
As part of preparations for a Phase 3 clinical trial to test its experimental therapy, masitinib, in people with amyotrophic…
It’s well established that some cases of amyotrophic lateral sclerosis (ALS) are caused by mutations that are inherited from…
A protein called UBQLN2 is key for regulating both proteins and fat molecules in nerve cells, and disruptions in these…
Two blood markers indicative of inflammation and cellular stress may help predict disease progression patterns and survival in people with…
Advocates and lawmakers are racing against a looming September deadline to prevent a “funding cliff” for critical amyotrophic lateral…
People living with amyotrophic lateral sclerosis (ALS) in the U.S. generally prefer care models where they can see multiple…